Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
NPPA Revises Ceiling Price of 4 Scheduled Formulation, Detail Dr. Divya Colin23 Aug 2024 6:00 PM ISTNew Delhi: Through a recent notice, after considering the Wholesale Price Index (WPI) impact at 0.00551% for the year 2024, the National...
Strides Pharma Science Singapore gets tentative USFDA approval for Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate tablets Ruchika Sharma16 Sept 2023 12:30 PM ISTBangalore: Strides Pharma Science Limited has announced that its step‐ down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore,...
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
USFDA tentative nod to Aurobindo Pharma's generic FDC drug to treat HIV in children Ruchika Sharma17 Aug 2023 1:30 PM ISTAurobindo has capacities in their FDA approved plant to meet the market demand for this product and commercial production will commence in Q3 FY24.
Novel HIV drug formulation could improve treatment outcomes for children globally Isra Zaman4 Aug 2023 9:30 AM ISTResearchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation...
NPPA fixes ceiling price of 12 Scheduled Formulations, Details Susmita Roy26 Dec 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices for 12 scheduled formulations...
Cipla, DNDi unveil 4-in-1 ARV formulation for kids with HIV Ruchika Sharma15 Jun 2022 12:00 PM ISTThe '4-in-1' combination contains an antiretroviral combination that is recommended by the World Health Organization (WHO) as an alternative...
CDSCO panel gives Emcure Pharma waiver on Phase IV CT for Lamivudine plus Dolutegravir Dr. Divya Colin27 April 2022 6:19 PM ISTNew Delhi: Pharmaceutical major, Emcure Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Laurus gets CDSCO panel nod to market anti retroviral FDC Tenofovir Alafenamide Fumarate,Lamivudine, Dolutegravir Dr. Divya Colin12 April 2022 7:29 PM ISTNew Delhi: Pharmaceutical major, Laurus has got the go ahead from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
Lupin bags USFDA nod for Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate Tablets under PEPFAR Ruchika Sharma30 Jun 2021 5:13 PM ISTMumbai: Global pharma major, Lupin Limited, today announced that the company has received tentative approval from the United States Food and Drug...
